Mycobacterium indicus pranii: Home-grown vaccine latest shot
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
On Sunday, an indigenous leprosy vaccine — the first such in the world — was launched as part of a pilot programme in several districts of Gujarat and in Bihar. The Mycobacterium indicus pranii (MIP) vaccine was developed entirely at the National Institute of Immunology (NII).

Apart from leprosy, the MIP vaccine is also being tried as a vaccine against bladder cancer, warts, lung cancer and TB. It has received approval as a leprosy vaccine from the Indian drug regulator, Central Drugs Standard Control Organisation, and the US Food and Drug Administration (FDA). If the field trials in four districts of Gujarat and two in Bihar, launched by Health Minister J P Nadda on Sunday, prove successful, the vaccine may be the country’s most potent weapon in the fight to eliminate a disease still dogged by social stigma.

The trials for this vaccine, which concluded in 2000-2001, found the vaccine’s efficacy to be about 70 per cent.

http://indianexpress.com/article/explained/home-grown-vaccine-latest-shot-at-checking-leprosy-numbers-4646778/
Preview
Like
Comment
Share